All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
UPlift
A post-marketing study of UPadacitinib evaluating speed of onset and durability of effectiveness for patients with moderate to severe Crohn’s disease for 3 years in the real-world
VECTORS
A study looking at bowel healing for patients
VIKTORIA-1
The purpose of this study is to evaluate the safety and effectiveness of gedatolisib at treating your cancer when combined with other cancer drugs, compared to the standard of care for people with breast cancer.
Whistle-PF a new oral treatment for patients with Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) or non-IPF Progressive Pulmonary Fibrosis (PPF)
X-ACKT: Clinical trial of a new drug for generalised epilepsy
X-TOLE2: Clinical trial of a new drug for focal epilepsy
XL092-304
The research project is testing a potential new treatment for nccRCC, called XL092 in a combination with nivolumab.
Zn-c3 - A potential new treatment for advanced ovarian, peritoneal or fallopian tube cancer
A potential new treatment for advanced ovarian, peritoneal or fallopian tube cancer.
ZN-c3-002
The purpose of this study is to test a potential new treatment for ovarian, peritoneal or fallopian tube cancer called ZN-c3-also known as azenosertib.
ZOvCa - A phase 1 PET-CT study of 89Zr-hu/mo-10D7 in patients with advanced epithelial Ovarian Cancer
The primary aim of this clinical trial is to test the safety of a new imaging agent in patients with epithelial ovarian cancer.